Therapeutic Potential of the Intestinal Microbiota for Immunomodulation of Food Allergies

Author(s)

Kreft, Luisa ^{[1, 2, 3]} ; Hoffmann, Christian ^{[1, 2, 3, 4]} ; Ohnmacht, Caspar ^{[1, 2, 3]}

Affiliation

^[1] German Ctr Lung Res DZL, Munich - Germany

^[2] Tech Univ, Mucosal Immunol Grp, Ctr Allery & Environm ZAUM, Munich - Germany

^[3] Helmholtz Ctr Munich, Munich - Germany

^[4] Univ Sao Paulo, Dept Food Sci & Expt Nutr, Food Res Ctr FoRC, Sch Pharmaceut Sci, Sao Paulo - Brazil

• Document type: Review article
• Source: FRONTIERS IN IMMUNOLOGY; v. 11, AUG 14 2020.
• Web of Science Citations: 0

Abstract

Food allergy is an atopic disease that is caused by the immune system targeting harmless food antigens that can result in life-threatening anaphylaxis. As humans and microbes have co-evolved, inevitably commensal microbes have a tremendous impact on our health. As such, the gut with its enormous microbial richness reflects a highly tolerogenic environment at steady state, in which immune cells are educated to react in a well-calibrated manner to food and microbial antigens. Recent evidence indicates that the susceptibility to food allergy is critically linked to microbial dysbiosis and can be transmitted by microbial transfer from humans to mice. Experimental work and epidemiological studies further point toward a critical time window in early childhood during which the immune system is imprinted by microbial colonization. Particularly, Foxp3-expressing regulatory T cells turn out to be key players, acting as rheostats for controlling the magnitude of food allergic reactions. An increasing number of bacterial metabolites has recently been shown to regulate directly or indirectly the differentiation of peripherally induced Tregs, most of which co-express the RAR-related orphan receptor gamma t (ROR gamma t). Genetic ablation provided additional direct evidence for the importance of ROR gamma t+ Tregs in food allergy. Future strategies for the stratification of food allergic patients with the aim to manipulate the intestinal microbiota by means of fecal transplantation efforts, pre- or probiotic regimens or for boosting oral immunotherapy may improve diagnosis and therapy. In this review some of the key underlying mechanisms are summarized and future directions for potential microbial therapy are explored. (AU)

• FAPESP's process: 19/14245-1 - Unraveling links between microbiome, food allergy and oral tolerance through meta-transcriptomic analysis of defined gut microbial communities
• Grantee: Christian Hoffmann
• Support Opportunities: Scholarships abroad - Research
• FAPESP's process: 13/07914-8 - FoRC - Food Research Center
• Grantee: Bernadette Dora Gombossy de Melo Franco
• Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC